Skip to main content

Advertisement

Figure 3 | BMC Cancer

Figure 3

From: Comparative benefit from small tumour size and adjuvant chemotherapy: clues for explaining breast cancer mortality decline

Figure 3

Adjuvant-CMF-related and tumour-size-related absolute mortality risk reduction (ARR) for 386 early breast cancer patients undergoing mastectomy only (179 patients) or mastectomy plus adjuvant CMF (207 patients). Adjuvant-CMF-related ARR = Mortality risk for controls - Mortality risk for CMF treated patients. Tumour-size-related ARR = Mortality risk for T1 – Mortality risk for T2/T3.

Back to article page